PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.6631
+0.0209 (3.25%)
At close: Jun 10, 2025, 4:00 PM
0.6800
+0.0169 (2.55%)
After-hours: Jun 10, 2025, 7:57 PM EDT
PAVmed Employees
PAVmed had 39 employees as of December 31, 2024. The number of employees decreased by 68 or -63.55% compared to the previous year.
Employees
39
Change (1Y)
-68
Growth (1Y)
-63.55%
Revenue / Employee
$51,103
Profits / Employee
$1,857,667
Market Cap
11.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PAVM News
- 7 days ago - PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute - PRNewsWire
- 14 days ago - Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - PRNewsWire
- 26 days ago - PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 27 days ago - Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 - PRNewsWire
- 5 weeks ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - PRNewsWire
- 6 weeks ago - NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - PRNewsWire